PLRX vs CAMP โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PLRX Captures Institutional Edge (2โ1 Pillars ยท 3โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pliant Therapeutics, Inc. Common Stock (PLRX) driven by superior Growth & Margin, Options & Structure while CAMP counters with relative strength in Momentum & Technical. Fundamentally, PLRX trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus CAMP at N/M Forward P/E and -991.8% operating margin (+138.9% YoY). In options structure, PLRX sits in UNCLASSIFIED (4th %ile IV; Dealer Gamma Walls on Pro) against CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | PLRX Revenue | CAMP Revenue | PLRX Op. Margin | CAMP Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $60M | N/A | -2.2% | N/A | PLRX |
| FY2020 | $40M | N/A | -99.6% | N/A | PLRX |
| FY2021 | $10M | N/A | -1288.1% | N/A | PLRX |
| FY2022 | $10M | N/A | -1313.4% | N/A | PLRX |
| FY2023 | $0M | $0M | -11654.7% | -14822.6% | PLRX |
| FY2024 | N/A | $0M | N/A | -8142.3% | CAMP |
| FY2025 | N/A | $0M | N/A | -1502.4% | CAMP |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PLRX | CAMP | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $43.2M | $238.5M | Larger Scale | CAMP |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -100.0% | +138.9% | Higher Growth | CAMP |
| Operating Margin (TTM) Profitability | 0.0% | -991.8% | Higher Margin | PLRX |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -50.3% | -146.1% | Higher ROE | PLRX |
| 52-Week Range Position Momentum | 0% ($1โ$2) | 23% ($3โ$8) | Stronger Trend | CAMP |
| Beta / 30D Volatility Risk Regime | 0.93ฮฒ ยท 37% Vol | 1.35ฮฒ ยท 94% Vol | Lower Realized Risk | PLRX |
| Unified Institutional Score Composite Signal | 39.0 / 100 (SELL) | 43.9 / 100 (HOLD) | Higher Composite | CAMP |